Excelsior BioPharma Inc. (6496)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
24. 95
+0.8
+3.3126%
NT$
- Market Cap
- P/E Ratio
110% Div Yield
2,475 Volume
- Eps
NT$ 24.15
Previous Close Want to track 6496 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Excelsior BioPharma Inc. (6496) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.51B
Trailing P/E (ttm) -5.73
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) 1.25
Price/Book (mrq) 1.52
Enterprise Value/Revenue 1.67
Enterprise Value/EBITDA -13.78
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 8.2K
Average volume (90 days) 12.04K
Price summary
52-Week low 22.5
52-Week high 30.55
Beta -
50-Day moving average 24.73
200-Day moving average 25.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Feb 2026
Ex-Dividend Date 27 Nov 2025
Last split factor 1:5
Last split Date 28 Nov 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.22%
Operating margin -0.21%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.24%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 19.5
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.81
Total debt (mrq) -
Total Debt/Equity (mrq) 0.69
Current ratio (mrq) 1.78%
Book value per share (mrq) 16.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
